Skip to main content
. 2019 May 20;60(4):235–243. doi: 10.4111/icu.2019.60.4.235

Table 2. Architecture of electronic case-report forms for Seoul National University Prospectively Enrolled Registry for Prostate Cancer-Radical Prostatectomy (SUPER-PC-RP).

Name of form Number of fields Entering type Description and examples
Study data & demographics 39 Once entering Study number, basic demographics and bio-banking information
Preop. characteristics 54 Once entering Initial PSA, biopsy information, past medical, social and family history
Preop. imaging 19 Once entering Results of magnetic resonance imaging and bone scan
Operation 38 Once entering Details of surgery
Pathology 50 Once entering Final pathology details
Postop. outcomes 9 Once entering Short-term postoperative results such as duration of hospital stay, cystography and Foley catheter removal date
Complication 31 Once entering Intraoperative, immediate, 30 and 90 days complications
Lab 35 Repeatedly entering Laboratory results (except PSA)
PSA 202 Revisingly entering PSA results
Medication & comorbidity 22 Repeatedly entering Information of medication and comorbidity
A/E 62 Repeatedly entering Post-treatment adverse events
IPSS 14 Repeatedly entering International Prostate Symptom Score questionnaire
EPIC-CP 26 Repeatedly entering Expanded Prostate Cancer Index Composite for Clinical Practice questionnaire
IIEF-5 9 Repeatedly entering International Index of Erectile Function-5 questionnaire
EQ-5D-5L 10 Repeatedly entering EuroQol health-related utility measurement tool
CARE questionnaire 35 Repeatedly entering Convalescence And Recovery Evaluation questionnaire
G8 10 Once entering Geriatric assessment by the G8
InBody 26 Repeatedly entering Body composition measurement by bio-electrical impedance analysis
Functional outcome summary 30 Revisingly entering Summarized results of continence and potency
Oncologic outcome summary 63 Revisingly entering Adjuvant or salvage treatment and oncologic outcome results

Preop., preoperative; postop., postoperative; PSA, prostate-specific antigen.